Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Aug-24 4:01 PM View:  | Holuka Eugene Myron Director | Citius Pharmaceuticals, Inc. (CTXR) | 13-Mar-24 | Option Exercise | 2,415 | $0.01 | $36.22 | 100% 0 to 2.42K | |
| 30-Aug-24 4:01 PM View: | Holuka Eugene Myron Director | Citius Pharmaceuticals, Inc. (CTXR) | 13-Mar-24 | Payment of Exercise | 48 | $0.75 | $36.00 | (2%) 2.42K to 2.37K | |
| 30-Aug-24 4:01 PM View: | Webb Carol Director | Citius Pharmaceuticals, Inc. (CTXR) | 04-Mar-24 | Payment of Exercise | 236 | $0.77 | $180.78 | (2%) 12.07K to 11.84K | |
| 30-Aug-24 4:01 PM View: | Webb Carol Director | Citius Pharmaceuticals, Inc. (CTXR) | 04-Mar-24 | Option Exercise | 12,071 | $0.01 | $181.07 | 100% 0 to 12.07K | |
| 27-Sep-19 4:15 PM View: | Holubiak Myron Z President and CEO Director 10% Owner | Citius Pharmaceuticals, Inc. (CTXR) | 27-Sep-19 | Purchase | 558,597 | $0.90 | $500,000.00 | 39% 1.43M to 1.99M | |
| 27-Sep-19 4:16 PM View: | Mazur Leonard L Executive Chairman Director 10% Owner | Citius Pharmaceuticals, Inc. (CTXR) | 27-Sep-19 | Purchase | 2,234,700 | $0.90 | $2,000,280.00 | 28% 8.02M to 10.26M | |
| 05-Apr-19 4:06 PM View: | Mazur Leonard L Executive Chairman Director 10% Owner | Citius Pharmaceuticals, Inc. (CTXR) | 03-Apr-19 | Purchase | 1,165,050 | $1.54 | $1,800,000.00 | 17% 6.86M to 8.02M | |
| 05-Apr-19 4:06 PM View: | Holubiak Myron Z President and CEO Director 10% Owner | Citius Pharmaceuticals, Inc. (CTXR) | 03-Apr-19 | Purchase | 129,450 | $1.54 | $200,000.00 | 10% 1.3M to 1.43M | |
| 15-Aug-18 5:06 PM View: | Holubiak Myron Z President and CEO Director 10% Owner | Citius Pharmaceuticals, Inc. (CTXR) | 13-Aug-18 | Market Purchase | 784,314 | $1.27 | $1,000,000.00 | 151% 519.89K to 1.3M | (6%) |
| 15-Aug-18 5:07 PM View: | Mazur Leonard L Executive Chairman Director 10% Owner | Citius Pharmaceuticals, Inc. (CTXR) | 13-Aug-18 | Market Purchase | 3,137,260 | $1.27 | $4,000,000.00 | 84% 3.72M to 6.86M | (6%) |
| 02-Apr-18 3:56 PM View: | Mazur Leonard L Executive Chairman Director 10% Owner | Citius Pharmaceuticals, Inc. (CTXR) | 29-Mar-18 | Market Purchase | 167,504 | $2.98 | $499,999.00 | 5% 3.55M to 3.72M | (60%) |
| 29-Mar-18 6:00 PM View: | Holubiak Myron Z President and CEO Director | Citius Pharmaceuticals, Inc. (CTXR) | 28-Mar-18 | Market Purchase | 2,915 | $3.09 | $9,007.35 | < 1% 516.97K to 519.88K | (61%) |
| 08-Jan-18 4:05 PM View: | Mazur Leonard L Executive Chairman Director 10% Owner | Citius Pharmaceuticals, Inc. (CTXR) | 19-Dec-17 | Market Purchase | 213,106 | $4.69 | $999,467.00 | 6% 3.34M to 3.55M | (74%) |
| 28-Aug-17 9:07 PM View: | Mazur Leonard L Executive Chairman Director 10% Owner | Citius Pharmaceuticals, Inc. (CTXR) | 24-Aug-17 | Market Purchase | 11,000 | $2.68 | $29,480.00 | < 1% 3.33M to 3.34M | (55%) |
| 10-Aug-17 6:07 PM View: | Mazur Leonard L Executive Chairman Director 10% Owner | Citius Pharmaceuticals, Inc. (CTXR) | 08-Aug-17 | Conversion | 1,547,070 | $3.09 | $4,780,440.00 | 114% 1.36M to 2.91M | (61%) |
| 10-Aug-17 6:07 PM View: | Mazur Leonard L Executive Chairman Director 10% Owner | Citius Pharmaceuticals, Inc. (CTXR) | 08-Aug-17 | Purchase | 421,400 | $4.12 | $1,738,280.00 | 15% 2.91M to 3.33M | |
| 08-Apr-16 9:53 AM View: | Holubiak Myron Z President and CEO Director | Citius Pharmaceuticals, Inc. (CTXR) | 30-Mar-16 | Acquisition (other) | 7,754,500 | -- | -- | 100% 0 to 7.75M | |
| 12-Apr-16 5:17 PM View: | Mazur Leonard L Director | Citius Pharmaceuticals, Inc. (CTXR) | 30-Mar-16 | Acquisition (other) | 15,116,700 | -- | -- | 100% 0 to 15.12M | |
| 12-Apr-16 5:17 PM View: | Mazur Leonard L Director | Citius Pharmaceuticals, Inc. (CTXR) | 30-Mar-16 | Private Purchase | 5,000,000 | $0.60 | $3,000,000.00 | 33% 15.12M to 20.12M |
